Page 4 - Nasdaq Hook News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq hook. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Hook Today - Breaking & Trending Today

HOOKIPA Announces Grant of Inducement Awards Under Nasdaq

NEW YORK and VIENNA, Austria, June 10, 2023 (GLOBE NEWSWIRE) HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of. ....

Reinhard Kandera , Exchange Commission , Pharma Inc , Company Common Stock , Compensation Committee , Common Stock , Nasdaq Listing Rule , Human Papillomavirus , Private Securities Litigation Reform Act , Nasdaq Hook , Hookipa Pharma Inc ,

HOOKIPA Pharma to Report First Quarter 2023 Financial

NEW YORK and VIENNA, Austria, May 04, 2023 (GLOBE NEWSWIRE) HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of. ....

Reinhard Kandera , Exchange Commission , Pharma Inc , Human Papillomavirus , Private Securities Litigation Reform Act , Nasdaq Hook , Hookipa Pharma Inc , Financial Results ,

Susquehanna International Group LLP Raises Position in Hookipa Pharma Inc (NASDAQ:HOOK)

Susquehanna International Group LLP raised its holdings in shares of Hookipa Pharma Inc (NASDAQ:HOOK – Get Rating) by 99.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,014 shares of the company’s stock after buying an additional 22,450 shares during the […] ....

Hookipa Pharma , Pharma Inc , Millennium Management , Susquehanna International Group , Goldman Sachs Group Inc , Securities Exchange Commission , Royal Bank , Renaissance Technologies , Hookipa Pharma Inc , Hookipa Pharma Company Profile , Get Rating , International Group , Street Corp , Sachs Group , Pharma Trading Down , Visit Holdingschannel , Hookipa Pharma Daily , Nasdaq Hook , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Hookipa Pharma (NASDAQ:HOOK) Trading Down 1%

Hookipa Pharma Inc (NASDAQ:HOOK – Get Rating) traded down 1% on Wednesday . The company traded as low as $0.72 and last traded at $0.72. 80,573 shares were traded during mid-day trading, a decline of 55% from the average session volume of 178,531 shares. The stock had previously closed at $0.73. Analyst Upgrades and Downgrades […] ....

Hookipa Pharma , Vanguard Group Inc , Hookipa Pharma Inc , Millennium Management , Alyeska Investment Group , Jefferies Financial Group Inc , Pharma Inc , Get Rating , Financial Group , Two Sigma Investments , Sigma Investments , Hookipa Pharma Daily , Nasdaq Hook ,

HOOKIPA announces positive Phase 1 data and Phase 2 plans

Alternating 2-vector therapy showed superior antigen-specific T cell responses, more robust anti-tumor activity and similar tolerability vs. single-vector. ....

United States , United Kingdom , Matt Beck , Siqing Fu , Joern Aldag , Michael Szumera , Exchange Commission , American Society Of Clinical Oncology , University Of Texas Md Anderson Cancer Center , Drug Administration , Pharma Inc , Human Papillomavirus , Clinical Oncology , Chief Executive Officer , Investigational Cancer Therapeutics , Cancer Center , Lymphocytic Choriomeningitis Virus , Pichinde Virus , Fast Track Designation , Private Securities Litigation Reform Act , Nasdaq Hook , Hookipa Pharma Inc ,